Skip to main content
. 2022 May 14;9(5):429–440. doi: 10.1093/nop/npac038

Table 3.

Montreal Cognitive Assessment (MoCA) Test Details by Visit Type

Clinic Visit Telehealth Visit Total
N 47 24 71
MoCA time Mean (SD), range 13:29 (03:25) 9:20-22:05 13:29 (03:25) 9:20-22:05
MoCA score Mean, SD 25 5 26 4 25 5
Median, range 26 6-30 27 12-30 27 6-30
n % n % n %
MoCA resulta Normal 31 66 17 71 48 68
Abnormal 16 34 7 29 23 32
Sex Female 23 49 10 42 33 46
Male 24 51 14 58 38 54
Ethnoracial group White/Hispanicb 8 17 4 17 12 17
White/non-Hispanic 35 75 20 83 55 78
Education High school 6 13 2 8 8 11
College 27 57 14 58 41 58
Graduate/professional 12 26 7 29 19 27
KPS 100 11 23 9 38 20 28
90 15 32 6 25 21 30
80 11 23 4 17 15 21
70 9 19 0 0 9 13
60 1 2 1 4 2 3
50 0 0 1 4 1 1
Recurrence No 27 57 14 58 41 58
Yes 20 43 10 42 30 42
Tumor grade Low 15 32 7 29 22 31
High 31 66 16 67 47 66
Radiation No 12 26 4 17 16 22
Yes 35 74 20 83 55 78
Levetiracetam use No 27 57 17 71 44 62
Yes 20 43 7 29 27 38
Dexamethasone use No 43 91 22 92 65 91
Yes 4 9 2 8 6 9
Sites Single 35 75 15 63 50 70
Multiple 11 23 9 38 20 28
Tumor side Right 22 47 13 54 35 49
Left 10 21 3 13 13 18
Posterior fossa 1 2 2 8 3 4
Brainstem/midline 2 4 1 4 3 4
Left + right 2 4 1 4 3 4
N/A 9 19 4 17 13 18
Frontal lobe involvement Frontal 15 32 10 42 25 35
Elsewhere 31 66 14 58 45 63

Abbreviations: KPS, Karnofsky performance status; SD, standard deviation.

aAbnormal = MoCA score ≤25.

bincludes Asian, Black/African American, Native Hawaiian/Pacific Islander, and Hispanic/Latino.